Item 2.02. Results of Operations and Financial Condition.

     On October 29, 2009, the Company issued a press release announcing its financial results for the quarter ended September 30, 2009. A copy of the release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

     The information in this section of this Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

Section 9 – Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

99.1

Press release announcing financial results dated October 29, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

		HUMAN GENOME SCIENCES, INC.
		By:		/s/ James H. Davis
		Name:		James H. Davis, Ph.D.
		Title:		Executive Vice President, General Counsel and Secretary

Date: November 2, 2009

INDEX TO EXHIBITS

Exhibit No.		Description
Exhibit 99.1		Press release announcing financial results dated October 29, 2009.